The prevalence of atopic dermatitis (AD) in industrialized countries has increased exponentially over the past three decades, currently affecting 15 to 30% of children and up to 10% of adults.1 At the recent official launch event of pimecrolimus (Elidel®, Meda Healthcare Sdn. Bhd.) held at Le Méridien Kuala Lumpur, Professor Thomas Luger provided insights on the pathophysiology of AD and the role of topical calcineurin inhibitors (TCIs) in the management of AD.
Nutrition and Behaviour Modification for Picky Eaters (NBMPE) is a management plan for children with mild picky eating habits. An NBMPE Expert Programme was recently conducted by three of the expert panelists in Kuala Lumpur, which saw the participation of more than 30 paediatricians from across the country. The highlights from the event are summarized here.
At the 57th Annual Scientific Congress of the Private Medical Practitioners Association of Selangor and Kuala Lumpur (PMPASKL), Professor Dr Jamal I-Ching Sam spoke on the impact of influenza in Malaysia and preventive strategies against it. Highlights from his presentation are summarized below.
In an exclusive interview with MIMS Doctor, Dr Yong Junina Fadzil, a consultant paediatrician and paediatric cardiologist at Klinik Pakar Kanak-Kanak Junina shared her perspectives on the roles of balanced nutrition and parental influence in child development.
The common cold is one of the most widespread illness and is a leading cause of visits to the doctor and absenteeism from school and work. While many may see it as merely a harmless inconvenience, the significant repercussions it brings, especially among children cannot be denied. MIMS JPOG recently spoke to Associate Professor Datin Dr Asmiati Abd Hamid to gain her perspectives on the role of zinc and vitamin C in treating paediatric common cold to reduce morbidity and economic losses attributed to the condition.
Plastic surgeon at KK
Women’s and Children’s Hospital, Dr Chia Hui Ling, talks about how physical deformities
can be devastating for a child’s development, and that it is crucial for
paediatric surgeons to understand unique issues and challenges involved when caring
for such conditions in children of all
At the recent Asia Pacific Alliance for the Control of Influenza (APACI) workshop in Kuala Lumpur, MIMS Doctor had the privilege of having an exclusive interview with eminent paediatric infectious disease specialist, Associate Professor Tawee Chotpitayasunondh. This article captures the highlights from our conversation with him.
At the ‘Allergy During Childhood: How to Overcome Long-Term Health Consequences’ Conference of the Malaysian Society of Allergy and Immunology (MSAI) held in Kuala Lumpur, paediatric consultant in allergy and immunology, Dr Zakiudin Munasir, spoke to MIMS Doctor about cow’s milk protein allergy (CMPA), with a focus on the role of soy-based formula.
Thalassaemia becomes a global health problem. Most women with thalassaemia trait can be picked up by universal prenatal screening for thalassaemia using mean corpuscular volume/haemoglobin, followed by haemoglobin pattern with or without DNA analysis.
Probiotics is defined as “live microorganisms which when administered in adequate amounts confer a health benefit on the host”. The therapeutic efficacy of probiotics has been studied extensively in the treatment of gastrointestinal microbial disorders, including diarrhoea. This article summarizes clinical papers on the topic of probiotics in the treatment of diarrhoea in children.
Synbiotics—mixtures of prebiotics and probiotics—are effective in the treatment of atopic dermatitis (AD), particularly if they contain mixed strains of bacteria and if they are given to children aged 1 year or older, according to a recent meta-analysis.
Early prediction of intraventricular haemorrhage (IVH) in preterm infants may be facilitated by mean diastolic blood pressure (DBP) and short-term scaling exponent from beat-to-beat DBP, systolic BP (SBP) and mean arterial pressure (MAP), reports a new study.
A fully automated bionic pancreas delivering insulin and glucagon with an autonomously adaptive dosing algorithm is to begin pivotal trial in the first half of 2017 after promising results from a randomized study in patients with type 1 diabetes mellitus (T1DM).